Patent details
EP2967015 Title: TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLES (MHC) CLASS II MOLECULES
Basic Information
- Publication number:
- EP2967015
- PCT Application Number:
- US2014023068
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP147188155
- PCT Publication Number:
- WO2014164638
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLES (MHC) CLASS II MOLECULES
- French Title of Invention:
- SOURIS TRANSGÉNIQUES EXPRIMANTS DES MOLÉCULES DU COMPLEXE MAJEUR D'HISTOCOMPATIBILITÉ (CMH) DE CLASSE II CHIMÉRIQUES
- German Title of Invention:
- TRANSGENE MÄUSE, DIE CHIMÄRE MHC-KLASSE-II-MOLEKÜLE EXPRIMIEREN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 30/06/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 30/06/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 11/03/2014
- Grant date:
- 07/06/2023
- EP Publication Date:
- 20/01/2016
- PCT Publication Date:
- 09/10/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/03/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Regeneron Pharmaceuticals, Inc.
- Address:
- 777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)
Inventor
1
- Name:
- GURER, Cagan
- Address:
- United States (US)
2
- Name:
- VORONINA, Vera
- Address:
- United States (US)
3
- Name:
- TU, Naxin
- Address:
- United States (US)
4
- Name:
- MURPHY, Andrew J.
- Address:
- United States (US)
5
- Name:
- MACDONALD, Lynn
- Address:
- United States (US)
6
- Name:
- STEVENS, Sean
- Address:
- United States (US)
Priority
- Priority Number:
- 201313793935
- Priority Date:
- 11/03/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A01K 67/027; C07K 14/74;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202609
- Publication date:
- 25/02/2026
- Description:
- Title of invention Modified
3
- Issue number:
- 202327
- Publication date:
- 05/07/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
4
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Document reprinted after correction (B8, B9)
5
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
6
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|